Exicure
Exicure, Inc. is an early-stage biotechnology company based in the United States, focused on developing nucleic acid therapies within the...
Facts
- HQ
- United States
- Sectors
- Biotechnology, Life Sciences
- Stage
- Early Stage
Exicure Announces Board Resignation and Two New Director Appointments, Expands Board to Six Members Effective June 30, 2026
Exicure, Inc. announced on June 24, 2026, board changes including the resignation of Jung Kyu Ham and appointments of Jin Young Go and Eui Seok Han, increasing the board size from five to six directors. The company also confirmed its Audit Committee composition and established a new Compensation Committee as it explores strategic alternatives following a restructuring.
